Shay Capital’s CVS Health CVS Stock Holding History

Shay Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,000	Closed	-$238K	–	528
2025 Q4	$238K	Sell	3,000 -2,000	-40%	-$158K	0.02%	393
2025 Q3	$377K	Buy	+5,000	New	+$343K	0.03%	284
2025 Q1	–	Sell	-14,280	Closed	-$641K	–	340
2024 Q4	$641K	Buy	+14,280	New	+$801K	0.1%	159
2024 Q1	–	Sell	-15,000	Closed	-$1.18M	–	398
2023 Q4	$1.18M	Buy	+15,000	New	+$1.07M	0.24%	80

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Shay Capital's CVS Position: Q1 2026 in Review

Shay Capital sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,000 shares — an estimated $238K sold.

Shay Capital first reported a position in CVS in Q4 2023 and held it in 4 quarters. The position peaked at $1.18M in Q4 2023. 1,877 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Shay Capital reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Shay Capital sold 3,000 CVS Health shares in Q1 2026, an estimated $238K.
Shay Capital first reported a position in CVS Health in Q4 2023 and held it in 4 quarters.
Shay Capital's CVS Health position peaked at $1.18M in Q4 2023.
1,877 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.